Greg Kunst is the founder of Aurion Biotechnologies. Backed by Deerfield, Alcon, Petrichor. Based in Seattle, WA.
Greg Kunst is the CEO of Aurion Biotechnologies, a clinical-stage biotech company developing regenerative cell therapies for vision restoration. He was recognized as Ernst & Young's 2024 Entrepreneur of the Year for the Mountain-West Region and received a Healthcare Leadership Award from the Puget Sound Business Journal.
Full founder directory · Investor directory · Company funding database · Fundraising library